Prevalence of female reproductive system tumors among patients at Al-Bayda Medical Center

Huda M. Abdallah Hassan; Raba M. Abdalkarim; Ruba Hussein Al Abweh; Marfoua. S. Ali

doi:10.54172/zxz4jg79

Authors

Huda M. Abdallah Hassan Department of Pathology, Faculty of Medicine, OMU, Al-Bayda, Libya Author
Raba M. Abdalkarim Department of Pathology, Faculty of Medicine, OMU, Al-Bayda, Libya Author
Ruba Hussein Al Abweh Cell Therapy and Applied Genomics (CTAG) Pathologist, King Hussein Cancer Center, Amman, Jordan. Author
Marfoua. S. Ali Department of Zoology, Faculty of Science, OMU, Al-Bayda, Libya Author

DOI:

https://doi.org/10.54172/zxz4jg79

Keywords:

Prevalence, Female genital tract tumors, gynecological specimens, Al-Bayda Medical Center (AMC).

Abstract

Female genital tract tumors are common and cause significant cancer morbidity and mortality worldwide. The prevalence of neoplasms according to their anatomical location depends on various cancer-associated predisposing factors. The present study aimed to estimate the prevalence of female reproductive system tumors among eastern Libyan females according to anatomical site and patient age. Gynecological specimens received in the pathology department of Al-Bayda Medical Center (AMC)-Libya, were studied, and the prevalence rate for each type of tumor was compared to regional and worldwide data.

Retrospective hospital-based research to analyze data of 936 gynecological specimens diagnosed over six years (January 2014-January 2020) at the Department of Pathology, Libya. A total of 936 gynecological specimens were reviewed corresponding to patients between 15 to 70 years of age. The majority of cases (293 cases; 45.9%) were endometrial tumors, leiomyomas (190 cases; 26.9%), ovarian tumors (214 cases; 33.4%) and gestational trophoblastic diseases (21 cases; 3.2%).

The least common tumors were uterine cervical tumors (15 cases; 2.1%). Benign tumors were most frequent in the second and fourth decades of life, while malignant neoplasms were most frequent from the fifth to eighth decades of life. Among eastern Libyan females from Al-Bayda region, the gynecological tumors with the highest incidence rate were endometrial tumors, followed by ovarian serous cystadenomas, then leiomyomas, gestational trophoblastic diseases and lastly uterine cervical tumors

References

1. E. W. Pass, L. F, Malignant Tumors of the Female Reproductive System. . SHaw Safety and Health at Work 3, 166 (2012).

2. WHO, The Global Cancer Observatory, World Health Organization International Agency for Research on Cancer, 2020).

3. ACS, American Cancer Society. https://www.cancer.org/1.800.227.2745, 2022).

4. A. Aburwais, S. Elgonoti, A. Rafael, J. Boder, F. Abdalla, Fathi, O. Alqawi, Demographic Features of Common Cancers in the National Cancer Institute, Misurata. Cancer 38, (2021).

5. J. Boder, E. Mostafa, A. Elmabrouk, B. Fathi, M. Elfageih, Ahmed, A. Abusaa, Y. Collan, Breast cancer patients in Libya: comparison with European and central African patients. Oncology letters 2, 323 (2011).

6. D. M. Parkin, The evolution of the population-based cancer registry. Nature Reviews Cancer 6, 603 (2006).

7. R. Kurman, M. Carcangiu, C. Herrington, R. Young, WHO classification of tumours of female reproductive organs. International Agency for Research on Cancer (IARC). 69372 Lyon Cedex 08, France. Research on Cancer (IARC). 69372 Lyon Cedex 08 63 (2014).

8. N. Almadani, E. F. Thompson, B. Tessier-Cloutier, J. Pors, L. Hoang, An update of molecular pathology and shifting systems of classification in tumours of the female genital tract. Diagnostic Histopathology 26, 278 (2020).

9. C. Parra-Herran, J. A. Bennett, What's new in gynecologic pathology 2021: vulva, cervix, and uterus. Journal of Pathology and Translational Medicine 55, 161 (2021).

10. J. Rosai, Rosai and Ackerman's surgical pathology e-book. Elsevier Health Sciences, (2011).

11. S. D. Reed, K. M. Newton, W. L. Clinton, M. Epplein, R. Garcia, K. Allison, N. S. Weiss, Incidence of endometrial hyperplasia. American journal of obstetrics and gynecology 200, 678. e1 (2009).

12. A. Zimmermann, D. Bernuit, C. Gerlinger, M. Schaefers, K. Geppert, Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC women's health 12, 1 (2012).

13. O. Yu, D. Scholes, R. Schulze-Rath, J. Grafton, K. Hansen, S. D. Reed, A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014. American Journal of Obstetrics and Gynecology 219, 591. e1 (2018).

14. S. M. Penny, Ovarian cancer: an overview. Radiologic Technology 91, 561 (2020).

15. D. C. Nnadi, S. Singh, Y. Ahmed, S. Siddique, S. Bilal, Histo-pathological features of genital tract malignancies as seen in a tertiary health center in north western Nigeria: A 10 year review. Annals of medical and health sciences research 4, 213 (2014).

16. G. Preeti, R. Saxena, Patterns of malignancies in female reproductive system: A five year retrospective study. International Journal of Clinical Obstetrics and Gynaecology 3, 74 (2019).

17. B. Kaur, Pathology of gestational trophoblastic disease (GTD). Best Practice & Research Clinical Obstetrics & Gynaecology 74, 3 (2021).

18. H. Y. Ngan, Y. S. Seckl, J. Michael, R. S. Berkowitz, Y. Xiang, F. Golfier, P. K. Sekharan, L. Massuger, Update on the diagnosis and management of gestational trophoblastic disease. International Journal of Gynecology & Obstetrics 143, 79 (2018).

19. G. Capobianco, E. Tinacci, L. Saderi, F. Dessole, M. Petrillo, M. Madonia, A. Cossu, Antonio. High incidence of gestational trophoblastic disease in a third-level university-hospital, Italy: A Retrospective cohort study. Frontiers in oncology 11, 684700 (2021).